Generation of antitumor immunity against large colon tumors by repeated runs of electrochemotherapy

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 770-774

  Gunji, Yoshio ^a,b   Uesato, Masaya ^a   Miyazaki, Shinichi ^a   Shimada, Hideaki ^a   Matsubara, Hisahiro ^a   Nabeya, Yoshihiro ^a   Kouda, Keiji ^a   Makino, Harufumi ^a   Kouzu, Teruo ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Antitumor immunity; Bleomycin; Colon carcinoma; Electroporation

Indexed keywords

BLEOMYCIN; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER INHIBITION; CELLULAR IMMUNITY; CLINICAL PROTOCOL; COLON TUMOR; CONTROLLED STUDY; ELECTRIC CURRENT; ELECTROCHEMOTHERAPY; ELECTRODE; ELECTROPORATION; FEMALE; IMMUNE RESPONSE; INFLAMMATORY CELL; MOUSE; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; OUTCOMES RESEARCH; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REGRESSION; TUMOR VOLUME;

ANIMALS; ANTIBODIES, NEOPLASM; BLEOMYCIN; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; ELECTROPORATION; FEMALE; INJECTIONS, INTRALESIONAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RETREATMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 20644445673     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mir LM, Orlowski S: The basis of electrochemotherapy. In: Jaroszeski MJ, Heller R, Gilbert R (Eds.). Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Electrically Mediated Delivery of Molecules to Cells. Totowa: Humana Press, 2000; pp. 99-117.
2. Sersa G: Electrochemotherapy: animal model work review. In: Jaroszeski MJ, Heller R, Gilbert T (Eds.). Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Electrically Mediated Delivery of Molecules to Cells. Totowa: Humana Press, 2000; pp. 119-136.
3. Heller R, Gilbert R, Jaroszeski MJ: Clinical trials of solid tumors using electrochemotherapy. In: Jaroszeski MJ, Heller R, Gilbert R (Eds.). Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Electrically Mediated Delivery of Molecules to Cells. Totowa: Humana Press, 2000; pp. 137-156.
4. Belehradek JrJ, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM: Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochem Biophys Acta 1994; 1190:105-103.
5. Mir LM, Orlowski S, Poddevin B, Belehradek JrJ: Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992; 3:331-334.
6. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek JrJ, Kourilsky P: Systemic antitumor effects of electrochemotherapy combined with histoincompatible cell secreting interleukin-2. J Immunother 1995; 17:30-38.
7. Kuriyama S, Mitoro A, Tsujinoue H, Toyokawa Y, Nakatani T, Yoshiji H, Tsujimoto T, Okuda H, Nagao S, Fukui H: Electrochemotherapy can eradicate established colorectal carcinoma and leave a systemic protective memory in mice. Int J Oncol 2000; 16:s979-985.
8. Jaroszeski MJ, Coppola D, Pottnger C, Benson K, Gilbert RA, Heller R: Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. Eur J Cancer 2001; 37:422-430.
9. Miyazaki S, Gunji Y, Matsubara H, Shimada H, Uesato M, Suzuki T, Kouzu T, Ochiai T: Possible involvement of antitumor immunity in the mechanism of eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin. Surg Today 2003; 33:39-44.
10. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek JJr, Mir LM: Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial Cancer 1993; 72:3694-3700.
11. Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek JJr, Mir LM: Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996; 77:956-963.
12. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, Deconti RC, Gilbert RA, Glass LF: Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83:148-157.
13. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z, Belehradek M, Gilbert R, Rols M-P, Belehrade JJr, Bachaud JM, DeContil R, Stabuc B, Cemazar M, Coninx P, Heler R: Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77:2336-2342.
14. Mir LM, Tounekti O, Orlowski S: Bleomycin: revival of an old drug. Gen Pharmacol 1996; 5:745-748.
15. Byrnes RW, Templin J, Sem D, Lyman S, Petering DH: Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins. Cancer Res 1990; 50:5275-5286.
16. Mir LM, Orlowski S, Belehradek JJr, Paoletti C: Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27:68-72.
17. Belehradek JJr, Orlowski S, Poddevin B, Paoletti C, Mir LM: Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991; 27:73-76.